Terbinafine Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 250 mg
Reference Brands: Lamisil(US & EU)
Category:
Anti-fungal
Terbinafine inhibits fungal squalene epoxidase, disrupting ergosterol synthesis and damaging cell membranes. It effectively treats dermatophyte skin and nail infections, offering rapid relief, high efficacy, and convenient oral dosing. Its safety and targeted action make it a preferred choice for superficial fungal infections.
Terbinafine Tablets is available in Tablets
and strengths such as 250 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Terbinafine Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Terbinafine Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Terbinafine tablets are approved in the EU and US for treating dermatophyte skin and nail infections. In the EU, Novartis’s Lamisil is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on comprehensive clinical data, biosimilarity, and pharmacovigilance. Both regions require detailed dossiers for initial approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and submissions, visit PharmaTradz. We ensure smooth market access for terbinafine tablets, helping you meet European and American standards for safe, effective antifungal therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing